Header cover image

Spanish (IBEX) Biotech Industry Analysis

UpdatedJan 27, 2023
DataAggregated Company Financials
  • 7D3.2%
  • 3M41.0%
  • 1Y-17.3%
  • YTD8.6%

Over the last 7 days, the Biotech industry has risen 3.2%, driven by gains from Grifols of 4.1%. However, the industry is down 17% over the past year. Earnings are forecast to grow by 27% annually.

Industry Valuation and Performance

Has the Spanish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 27 Jan 2023€8.7b€5.5b€137.1m78x63.6x1.6x
Sun, 25 Dec 2022€7.9b€5.5b€137.0m69.3x58x1.5x
Tue, 22 Nov 2022€7.5b€5.5b€136.9m63.9x54.4x1.4x
Thu, 20 Oct 2022€6.2b€5.5b€136.8m53.5x45.4x1.1x
Sat, 17 Sep 2022€8.3b€5.5b€136.8m73.2x60.6x1.5x
Mon, 15 Aug 2022€9.3b€5.5b€136.8m84.9x68.1x1.7x
Wed, 13 Jul 2022€11.1b€5.2b€266.2m37.9x41.9x2.2x
Fri, 10 Jun 2022€12.4b€5.2b€266.4m41.8x46.6x2.4x
Sun, 08 May 2022€12.3b€5.2b€266.3m41.7x46.2x2.4x
Tue, 05 Apr 2022€11.7b€5.2b€268.5m39.4x43.6x2.3x
Thu, 03 Mar 2022€11.5b€5.1b€236.6m41.1x48.6x2.2x
Sat, 29 Jan 2022€10.4b€5.4b€721.7m16x14.4x1.9x
Mon, 27 Dec 2021€10.5b€5.4b€721.8m16.5x14.6x2x
Wed, 24 Nov 2021€11.4b€5.4b€721.7m17.4x15.8x2.1x
Fri, 22 Oct 2021€13.3b€5.4b€729.0m20.2x18.2x2.4x
Sun, 19 Sep 2021€14.2b€5.4b€729.0m21.8x19.5x2.6x
Tue, 17 Aug 2021€13.3b€5.4b€729.0m18.6x18.3x2.5x
Tue, 01 Jun 2021€15.1b€5.5b€648.5m19.7x23.3x2.8x
Fri, 05 Mar 2021€14.5b€5.6b€750.7m17.3x19.3x2.6x
Mon, 07 Dec 2020€16.1b€5.6b€830.9m16.4x19.4x2.9x
Thu, 10 Sep 2020€14.9b€5.6b€677.0m18.2x22x2.7x
Wed, 03 Jun 2020€17.9b€5.4b€765.4m21.3x23.5x3.3x
Sat, 07 Mar 2020€17.7b€5.1b€618.5m28x28.6x3.5x
Price to Earnings Ratio


Total Market Cap: €18.4bTotal Earnings: €618.5mTotal Revenue: €5.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Biotech Industry Price to Earnings3Y Average 30.2x202120222023
Current Industry PE
  • Investors are optimistic on the Spanish Biotechnology industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 63.6x which is higher than its 3-year average PE of 30.2x.
  • The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have declined 39% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Spanish Biotech compare with similar industries?

ES Market2.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GRF Grifols€12.564.1%
ORY Oryzon Genomics€2.611.0%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News



Pharma Mar














Oryzon Genomics